Trial Profile
Clinical Trials Insight: 700029239
Status:
Not stated
Phase of Trial:
Phase I
Latest Information Update: 13 Dec 2007
Price :
$35
*
At a glance
- Drugs VRDN 001 (Primary)
- Indications Solid tumours
- Focus Therapeutic Use
- Sponsors Sanofi
- 13 Dec 2007 New trial record.